Luo Wenting, Huang Huimin, Zheng Peiyan, Zheng Jinping, Sun Baoqing
Department of Allergy and Clinical Immunology, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, People's Republic of China.
J Asthma Allergy. 2021 Apr 28;14:439-447. doi: 10.2147/JAA.S302920. eCollection 2021.
The presence of cross-reactive carbohydrate determinants (CCDs) may cause false-positive results in vitro allergen sIgE tests. In this paper, we focused on pollen sensitisation and its relationship with CCD in patients with respiratory allergic diseases in South China. A CCD inhibition test was conducted to assess whether patients were truly allergic to pollen or whether their sIgE was caused by a CCD cross-reaction, thus providing an important basis for clinical diagnosis and treatment.
Patients with known serologic pollen sensitization were selected, and sIgE of mugwort, tree mix 20 (willow/poplar/elm tree), common ragweed, , peanut, soybean and CCD was detected via the EUROBlotMaster system. Thirteen CCD-sIgE negative patients and 33 CCD-positive patients were selected, and their serum samples were subjected to the CCD inhibition test.
We found that 66.0% to 95.9% of patients sensitised to pollen and seed food allergens were co-sensitized to CCD. Additionally, 73.0% to 100% of the sIgE tests for pollen and seed food allergens turned negative after inhibition, mostly for allergens from (100%, 15/15), followed by mugwort and peanut (85.2%, 23/27), ragweed (81.5%, 22/27), soybean (80.0%, 20/25), and tree pollen (73.0%, 19/26).
CCD causes false positives in the in vitro allergen sIgE tests of patients with respiratory allergic diseases in South China. Attention should be paid to the use of CCD inhibitors in diagnosing in vitro allergies because of their importance in diagnosing and treating local allergic diseases.
交叉反应性碳水化合物决定簇(CCDs)的存在可能会在体外变应原特异性IgE(sIgE)检测中导致假阳性结果。在本文中,我们聚焦于中国南方呼吸道过敏性疾病患者的花粉致敏情况及其与CCDs的关系。进行了CCDs抑制试验,以评估患者是否真的对花粉过敏,或者其sIgE是否由CCDs交叉反应引起,从而为临床诊断和治疗提供重要依据。
选取已知血清学花粉致敏的患者,通过EUROBlotMaster系统检测艾蒿、混合树花粉20(柳树/杨树/榆树)、豚草、花生、大豆和CCDs的sIgE。选取13例CCDs-sIgE阴性患者和33例CCDs阳性患者,对其血清样本进行CCDs抑制试验。
我们发现,对花粉和种子食物变应原致敏的患者中有66.0%至95.9%对CCDs也致敏。此外,花粉和种子食物变应原的sIgE检测在抑制后73.0%至100%变为阴性,主要是对[未提及的变应原](100%,15/15),其次是艾蒿和花生(85.2%,23/27)、豚草(81.5%,22/27)、大豆(80.0%,20/25)和树花粉(73.0%,19/26)。
CCDs在中国南方呼吸道过敏性疾病患者的体外变应原sIgE检测中导致假阳性。由于其在诊断和治疗局部过敏性疾病中的重要性,在体外过敏诊断中应注意使用CCDs抑制剂。